Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.67 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.67 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.58 |
| ▸ | GAA | P10253 | 1/20 | 0.58 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.58 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | APEX1 | P27695 | 1/20 | 0.34 |
| ▸ | TTR | P02766 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30146940 | 0.88 | MEN1 (0.44) | MEN1KMT2AKDM4EGAACYP2C9 | |
| SCHEMBL11554769 | 0.82 | MEN1 (1.00) | MEN1KMT2AKDM4EGAACYP2C9 | |
| Morpholine SCHEMBL8649532 | 0.82 | MEN1 (1.00) | MEN1KMT2AKDM4EGAACYP2C9 | |
| SCHEMBL27350 | 0.82 | MEN1 (1.00) | MEN1KMT2AKDM4EGAACYP2C9 | |
| SCHEMBL11584070 | 0.82 | MEN1 (1.00) | MEN1KMT2AKDM4EGAACYP2C9 | |
| SCHEMBL25148109 | 0.82 | MEN1 (1.00) | MEN1KMT2AKDM4EGAACYP2C9 | |
| SCHEMBL11559655 | 0.82 | MEN1 (1.00) | MEN1KMT2AKDM4EGAACYP2C9 | |
| SCHEMBL7747664 | 0.82 | MEN1 (1.00) | MEN1KMT2AKDM4EGAACYP2C9 | |
| SCHEMBL111814 | 0.82 | MEN1 (1.00) | MEN1KMT2AKDM4EGAACYP2C9 | |
| SCHEMBL59830 | 0.82 | MEN1 (1.00) | MEN1KMT2AKDM4EGAACYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5288718-A | Desorption the formed complexes by administering tetraoxa-diazacyclooctadecane dimalonic acid tetrasodium salt | ORSZAGOS "FREDERIC JOLIOT-CURIE" SUGARBIOLOGIAI ES SUGAREGESZSEGUGYI KUTATO INTEZET (HU) | 1994-02-22 | — | — | US | claimed |
| US-20250090700-A1 | HUMANIZED ANTIBODY THAT BINDS TO HEG1 PROTEIN AND COMPLEX OF ANTIBODY AND RADIONUCLIDE | KANAGAWA PREFECTURAL HOSPITAL ORGANIZATION (JP) | 2025-03-20 | — | — | US | disclosed |
| EP-1838617-B1 | CALCIUM POTASSIUM FERROCYANIDE, A PROPHYLACTIC MIXTURE COMPRISING THIS COMPOUND AND THE USE THEREOF FOR DECORPORATION OF RADIOCESIUM IN SUBJECTS AFFECTED BY NUCLEAR RADIATION | SECRETARY DEPT ATOMIC ENERGY (IN) | 2013-07-31 | — | — | EP | disclosed |
| US-7935366-B2 | mixture with Calcium Iodate, and Calcium Carbonate for removal of all three radionuclides Cesium, Strontium, Iodine | SECRETARY, DEPARTMENT OF ATOMIC ENERGY (IN) | 2011-05-03 | — | — | US | disclosed |
| US-20080145448-A1 | Calcium Potassium Ferrocyanide, a Prophylactic Mixture Comprising this Compound and the Use Thereof for Decorporation of Radiocesium in Subjects Affected by Nuclear Radiation | SECRETARY, DEPARTMENT OF ATOMIC ENERGY GOVERNMENT OF INDIA (IN) | 2008-06-19 | — | — | US | disclosed |
| EP-0426824-A1 | METHOD FOR THE PREPARATION OF ACTIVE INGREDIENTS AND PHARMACEUTICAL COMPOSITIONS FOR DECORPORATING RADIOACTIVE ISOTOPES FROM LIVING ORGANISMS | ORSZAGOS "FREDERIC JOLIOT-CURIE" SUGARBIOLOGIA ES SUGAREGESZSEGUGYI KUTATO INTEZET (HU) | 1991-05-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250090700-A1 | HUMANIZED ANTIBODY THAT BINDS TO HEG1 PROTEIN AND COMPLEX OF ANTIBODY AND RADIONUCLIDE | HIRIP3, PPHLN1, FRG1 | MEN1 16/4885KMT2A 1777/4885KDM4E 3312/4885 |
| US-20080145448-A1 | Calcium Potassium Ferrocyanide, a Prophylactic Mixture Comprising this Compound and the Use Thereof for Decorporation of Radiocesium in Subjects Affected by Nuclear Radiation | NEK6, NEK9, CASK | MEN1 453/4885KMT2A 3551/4885KDM4E 2081/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.